Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Uijen MJM"" wg kryterium: Autor


Wyświetlanie 1-4 z 4
Tytuł :
68Ga-Prostate-Specific Membrane Antigen-11-Avid Cardiac Metastases in a Patient With Adenoid Cystic Carcinoma, A Rare Presentation of a Rare Cancer.
Autorzy :
Uijen MJM; From the Department of Medical Oncology, Radboud Institute for Health Sciences.
van Boxtel W; From the Department of Medical Oncology, Radboud Institute for Health Sciences.
van Herpen CML; From the Department of Medical Oncology, Radboud Institute for Health Sciences.
Gotthardt M; Department of Radiology, Nuclear Medicine and Anatomy, Radboud University Medical Center, Nijmegen, the Netherlands.
Nagarajah J
Pokaż więcej
Źródło :
Clinical nuclear medicine [Clin Nucl Med] 2020 Sep; Vol. 45 (9), pp. 716-718.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Oligopeptides*
Positron Emission Tomography Computed Tomography*
Carcinoma, Adenoid Cystic/*pathology
Edetic Acid/*analogs & derivatives
Heart Neoplasms/*diagnostic imaging
Heart Neoplasms/*secondary
Aged ; Humans ; Male
Czasopismo naukowe
Tytuł :
Systemic therapy in the management of recurrent or metastatic salivary duct carcinoma: A systematic review.
Autorzy :
Uijen MJM; Department of Medical Oncology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.
Lassche G; Department of Medical Oncology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.
van Engen-van Grunsven ACH; Department of Pathology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.
Tada Y; Department of Head and Neck Oncology and Surgery, International University of Health and Welfare Mita Hospital, Tokyo, Japan.
Verhaegh GW; Department of Urology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.
Schalken JA; Department of Urology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.
Driessen CML; Department of Medical Oncology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.
van Herpen CML; Department of Medical Oncology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands. Electronic address: .
Pokaż więcej
Źródło :
Cancer treatment reviews [Cancer Treat Rev] 2020 Sep; Vol. 89, pp. 102069. Date of Electronic Publication: 2020 Jul 15.
Typ publikacji :
Journal Article; Systematic Review
MeSH Terms :
Carcinoma, Ductal/*drug therapy
Neoplasm Recurrence, Local/*drug therapy
Salivary Ducts/*pathology
Salivary Gland Neoplasms/*drug therapy
Carcinoma, Ductal/metabolism ; Carcinoma, Ductal/pathology ; Clinical Trials as Topic ; Humans ; Neoplasm Metastasis ; Neoplasm Recurrence, Local/metabolism ; Neoplasm Recurrence, Local/pathology ; Palliative Care/methods ; Receptor, ErbB-2/metabolism ; Salivary Ducts/metabolism ; Salivary Gland Neoplasms/metabolism ; Salivary Gland Neoplasms/pathology
Czasopismo naukowe
Tytuł :
Prognostic value of PSMA, c-MET and E-cadherin in salivary duct carcinoma.
Autorzy :
van Boxtel W; Department of Medical Oncology, Radboud Institute for Health Sciences, Radboud university medical center, Nijmegen, the Netherlands.
Uijen MJM; Department of Medical Oncology, Radboud Institute for Health Sciences, Radboud university medical center, Nijmegen, the Netherlands.
Verhaegh GW; Department of Urology, Radboud Institute for Molecular Life Sciences, Radboud university medical center, Nijmegen, the Netherlands.
Willems SM; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands; Department of Pathology and Medical Biology, University Medical Center Groningen, Groningen, the Netherlands.
Jonker MA; Department of Health Evidence, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.
Schalken JA; Department of Urology, Radboud Institute for Molecular Life Sciences, Radboud university medical center, Nijmegen, the Netherlands.
van Engen-van Grunsven ICH; Department of Pathology, Radboud Institute for Health Sciences, Radboud university medical center, Nijmegen, the Netherlands.
van Herpen CML; Department of Medical Oncology, Radboud Institute for Health Sciences, Radboud university medical center, Nijmegen, the Netherlands. Electronic address: .
Pokaż więcej
Corporate Authors :
PALGA Group
Źródło :
Oral oncology [Oral Oncol] 2020 Nov; Vol. 110, pp. 105018. Date of Electronic Publication: 2020 Oct 08.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Lutetium-177-PSMA-617 in Low-Volume Hormone-Sensitive Metastatic Prostate Cancer: A Prospective Pilot Study.
Autorzy :
Privé BM; Department of Radiology and Nuclear Medicine, Radboudumc, Nijmegen, the Netherlands.
Peters SMB; Department of Radiology and Nuclear Medicine, Radboudumc, Nijmegen, the Netherlands.
Muselaers CHJ; Department of Urology, Radboudumc, Nijmegen, the Netherlands.
van Oort IM; Department of Urology, Radboudumc, Nijmegen, the Netherlands.
Janssen MJR; Department of Radiology and Nuclear Medicine, Radboudumc, Nijmegen, the Netherlands.
Sedelaar JPM; Department of Urology, Radboudumc, Nijmegen, the Netherlands.
Konijnenberg MW; Department of Radiology and Nuclear Medicine, Radboudumc, Nijmegen, the Netherlands.; Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, the Netherlands.
Zámecnik P; Department of Radiology and Nuclear Medicine, Radboudumc, Nijmegen, the Netherlands.
Uijen MJM; Department of Radiology and Nuclear Medicine, Radboudumc, Nijmegen, the Netherlands.
Schilham MGM; Department of Radiology and Nuclear Medicine, Radboudumc, Nijmegen, the Netherlands.
Eek A; Department of Radiology and Nuclear Medicine, Radboudumc, Nijmegen, the Netherlands.
Scheenen TWJ; Department of Radiology and Nuclear Medicine, Radboudumc, Nijmegen, the Netherlands.
Verzijlbergen JF; Department of Radiology and Nuclear Medicine, Radboudumc, Nijmegen, the Netherlands.
Gerritsen WR; Department of Medical Oncology, Radboudumc, Nijmegen, the Netherlands.
Mehra N; Department of Medical Oncology, Radboudumc, Nijmegen, the Netherlands.
Kerkmeijer LGW; Department of Radiation Oncology, Radboudumc, Nijmegen, the Netherlands.
Smeenk RJ; Department of Radiation Oncology, Radboudumc, Nijmegen, the Netherlands.
Somford DM; Department of Urology, Canisius Wilhelmina Hospital, Nijmegen, the Netherlands.
van Basten JA; Department of Urology, Canisius Wilhelmina Hospital, Nijmegen, the Netherlands.
Heskamp S; Department of Radiology and Nuclear Medicine, Radboudumc, Nijmegen, the Netherlands.
Barentsz JO; Department of Radiology and Nuclear Medicine, Radboudumc, Nijmegen, the Netherlands.
Gotthardt M; Department of Radiology and Nuclear Medicine, Radboudumc, Nijmegen, the Netherlands.
Witjes JA; Department of Urology, Radboudumc, Nijmegen, the Netherlands.
Nagarajah J; Department of Radiology and Nuclear Medicine, Radboudumc, Nijmegen, the Netherlands. .; Department of Nuclear Medicine, Technische Universität München, Klinikum rechts der Isar, München, Germany.
Pokaż więcej
Źródło :
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 Apr 21. Date of Electronic Publication: 2021 Apr 21.
Typ publikacji :
Journal Article
Czasopismo naukowe
    Wyświetlanie 1-4 z 4

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies